Biotech Values

[semi_infinite]

MYOK - Ok thx. I wasn't paying attn to their earnings at all and I didn't think anybody else would be either at this stage. I read the CC transcript and there was nothing obvious in there other than perhaps a higher rate of spending to conduct all 6 trials and continued uncertainty wrt what the FDA wants on hcm trials. 491 potentially interesting. The rest I am not sure of given the nature of HF. Short the 45/55 strangle (triggered when the drop happened) that will expire tomorrow.